Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-12-19 00:00:00 ET · period of report 2025-12-17 · accession 0001323212-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-19 | 2025-12-17+ | PTCT | Pauwels Eric | Chief BUSINESS Off | M - OptEx | $62.10 | +43.5K | 73.2K | +146% | +$2.70M |
| DM | 2025-12-19 | 2025-12-17+ | PTCT | Pauwels Eric | Chief BUSINESS Off | S - Sale+OE | $75.40 | -43.5K | 70.5K | -38% | -$3.28M |
| DM | 2025-12-19 | 2025-12-17+ | PTCT | Pauwels Eric | Chief BUSINESS Off | M - OptEx | $0.00 | -43.5K | 22.9K | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-17 | M | A | 1,245 | $66.49 | 74,157 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-17 | S | D | 1,245 | $75.28 | 72,912 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-12-17 | M | A | 3,684 | $18.01 | 74,157 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-17 | S | D | 3,584 | $75.31 | 70,473 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-12-17 | S | D | 100 | $76.00 | 70,373 | D | — | — | |
| 6 | Common | Common Stock | 2025-12-17 | M | A | 35,361 | $66.49 | 105,734 | D | — | — | |
| 7 | Common | Common Stock | 2025-12-18 | S | D | 2,831 | $75.07 | 70,373 | D | — | — | (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.20 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2025-12-17 | S | D | 100 | $76.00 | 70,373 | D | — | — | |
| 9 | Common | Common Stock | 2025-12-18 | M | A | 120 | $66.49 | 70,493 | D | — | — | |
| 10 | Common | Common Stock | 2025-12-18 | S | D | 120 | $75.02 | 70,373 | D | — | — | (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.18 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 11 | Common | Common Stock | 2025-12-18 | M | A | 251 | $18.01 | 70,624 | D | — | — | |
| 12 | Common | Common Stock | 2025-12-18 | S | D | 251 | $75.00 | 70,373 | D | — | — | |
| 13 | Common | Common Stock | 2025-12-18 | M | A | 2,831 | $66.49 | 73,204 | D | — | — | |
| 14 | Common | Common Stock | 2025-12-17 | S | D | 35,261 | $75.44 | 70,473 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 15 | Derivative | Stock Option (Right to Buy) | 2025-12-18 | M | D | 251 | $0.00 | 18,131 | D | $18.01 · — to 2028-01-02 | 251 Common Stock | (F7) Currently exercisable. |
| 16 | Derivative | Stock Option (Right to Buy) | 2025-12-18 | M | D | 2,951 | $0.00 | 19,943 | D | $66.49 · — to 2031-01-05 | 2,951 Common Stock | (F7) Currently exercisable. |
| 17 | Derivative | Stock Option (Right to Buy) | 2025-12-17 | M | D | 3,684 | $0.00 | 18,382 | D | $18.01 · — to 2028-01-02 | 3,684 Common Stock | (F7) Currently exercisable. |
| 18 | Derivative | Stock Option (Right to Buy) | 2025-12-17 | M | D | 36,606 | $0.00 | 22,894 | D | $66.49 · — to 2031-01-05 | 36,606 Common Stock | (F7) Currently exercisable. |